Verge Genomics Announced Milestones In Collaboration With Lilly To Discover And Develop Novel Treatments For ALS; Lilly To Develop Two Targets Identified By Verge Genomics
Verge Genomics Announced Milestones In Collaboration With Lilly To Discover And Develop Novel Treatments For ALS; Lilly To Develop Two Targets Identified By Verge Genomics
Verge Genomics宣佈與Lilly合作在發現和開發治療ALS的新療法方面取得里程碑；Lilly將開發Verge Genomics確定的兩個治療靶點。
— Lilly to Develop Two Targets Identified and Validated Using Verge Genomics' AI-Enabled, All-in-Human CONVERGE Platform
— 莉莉將開發兩個使用Verge Genomics的人工智能支持的全人類CONVERGE平台識別和驗證的目標
— Demonstration of the Robust Predictive Power of CONVERGE - 83% of Prioritized Targets were Validated in Disease-Relevant Models, a Rate Significantly Higher than Industry Standards
— 展示CONVERGE的強大預測能力 - 83%的優先目標在與疾病相關的模型中得到了驗證，驗證率顯著高於所有板塊標準
熱門討論
科技巨頭財報季如火如荼，英偉達壓軸會表現如何？
週四， $亞馬遜 (AMZN.US)$ 該公司報告第四季度調整後每股收益爲1.86美元，高於1.50美元的預期，營業收入爲1877.9亿美元，高於1873.2亿美元的預期。公司預測下一季度營收將低於華爾街的預期，預計本季度最多爲1550亿美元，而分析師們希望達到1580亿美元。
Moo Earnings
02/02 12:39
亞馬遜收益預覽：通過猜測開盤價格獲得獎勵！